MedTrace Logo

Optimal Treatment of MRSA Throat Carriers

NCT04104178 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2025-09-24

No results posted yet for this study

Summary

The aim of this study is to investigate the optimal way to treat MRSA throat carriers.

Conditions

  • MRSA
  • MRSA Colonization

Interventions

DRUG

Clindamycin

Investigating whether a significantly higher number of MRSA throat carriers succeed in becoming MRSA free, when using Clindamycin on top of our general recommended topical treatment of Mupirocin nasal ointment + chorhexidin baths

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Hvidovre University Hospital

    lead OTHER

Principal Investigators

  • Mona KA Holm, MD · Hvidovre University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-20
Primary Completion
2025-09-18
Completion
2025-09-18

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04104178 on ClinicalTrials.gov